Substance Use Disorder

AHA comments proposed revisions to the regulations governing the confidentiality of substance use disorder (SUD) records, commonly known as 42 CFR Part 2 (“Part 2”).
States, territories, health facilities and tribal organizations can apply through March 27 for up to $525,000 million each for residential treatment programs to provide comprehensive services for pregnant and postpartum women with substance use disorders, the Substance Abuse and Mental Health…
Over 46 million Americans aged 12 and older had a substance use disorder in 2021, 16.5% of the population, only 6% of whom received treatment, according to the latest National Survey of Drug Use and Health.
The number of health care providers with waivers to prescribe buprenorphine for opioid use disorder increased 19% between October 2021 and September 2022 to 132,005, HHS announced.
The AHA urges the DEA to release proposed rules for the Special Registration for Telemedicine as soon as possible. Doing so is necessary to ensure an appropriate feedback period and time for hospitals and health systems to comply with requirements.
In this proposed rule, HHS seeks to revise, delete, replace or add regulatory language to the Part 2 regulations to align them with those under HIPAA, as well as to improve clarity or readability. The agency notes that it will issue a separate rule on CARES Act provisions related to…
The Department of Health and Human Services today issued a notice of public rulemaking to improve the exchange of patient records used in the treatment of substance use disorder.
Rural America is in crisis. A spike in suicides and deaths by substance abuse has strained communities already struggling with a lack of clinical and inpatient resources. But there is hope. Led by their local health systems, two rural communities in Colorado and North Carolina have rallied to meet…
The number of drug overdose deaths in America increased by nearly 30% from 2019 to 2020.
The House voted 220-205 today to pass legislation to hold employer-based health plans more accountable for improper denials of mental health and substance use benefits.